Since the general mechanism of BCG response is through generation of an inflammatory response at the tumor site, we believe that pre-existing inflammation as a result of activated NF-κB hampers the ability of BCG to produce substantial inflammatory response to kill the tumor. Here, NFKB1 is linked to neoplasm.